Entries by admin

Eden Biologics Introduces New Chief Executive Officer, Dr. Steve Lee

Eden Biologics, Inc., a leading global biotechnology company based in Hsinchu, Taiwan, announced on September 1st, the appointment of Dr. Steve Lee, an accomplished biotech executive with broad experience and entrepreneurial leadership, as the new CEO and Director of the Board, effective immediately.

Eden Biologics’ Leading Biosimilar Program Receives Phase 3 Approval in Europe

We’ve once again achieved a huge corporate milestone and are excited to share the great news with all of you! Our EB-CLIN-1001-03 Phase 3 Clinical Trial for our leading Biosimilar Program EB1001, received approval from Hungary’s National Institute of Pharmacy and Nutrition (OGYÉI), as well as the Ethics Committee!

Eden Biologics Statement

Earlier this week, the United States Department of Justice announced that it has filed criminal charges against Racho Jordanov and Rose Lin, former employees of JHL Biotech (the predecessor to Eden Biologics), relating to alleged theft of trade secrets from Genentech.

JHL Biotech Officially Changes Name to EDEN Biologics

JHL Biotech, Inc., a global frontrunner in large-molecule biological drug development and manufacturing platform technologies, is excited to announce today that it has changed its corporate name to Eden Biologics, Inc.